You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DFTX Sale Disclosure
Karlin Daniel · SEC Form 4 · Filed Sep 29, 2026
Sale
Calculated transaction value
$396.89K
Karlin Daniel Chief Medical Officer
DFTX
Transaction date
Sep 25, 2026
Public filing date
Sep 29, 2026
Filing lag
Filed 4 days later
DFTX daily price context
Close on/before transaction
$36.17
Sep 25, 2026
First close after public filing
$38.06
Sep 30, 2026
30-day return after filing
-0.26%
Through Oct 29, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 10,853 shares @ $36.57
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001104659-26-112065
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$396.89K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Definium Therapeutics, Inc. DFTX Current | Sale | Sep 25, 2026 | $396.89K |